102 related articles for article (PubMed ID: 21659422)
1. Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: a follow-up study.
Arora V; Grover R; Kumar A; Anand D; Das N
Lupus; 2011 Oct; 20(10):1010-8. PubMed ID: 21659422
[TBL] [Abstract][Full Text] [Related]
2. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
3. Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-gamma and immune complex.
Arora V; Mondal AM; Grover R; Kumar A; Chattopadhyay P; Das N
Mol Immunol; 2007 Mar; 44(7):1722-8. PubMed ID: 17049990
[TBL] [Abstract][Full Text] [Related]
4. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
5. Expression and significance of leukocyte membrane cofactor protein transcript in systemic lupus erythematosus.
Biswas B; Kumar U; Das N
Lupus; 2012 Apr; 21(5):517-25. PubMed ID: 22247341
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
7. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
8. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
[TBL] [Abstract][Full Text] [Related]
9. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
10. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.
Hong SD; Reiff A; Yang HT; Migone TS; Ward CD; Marzan K; Shaham B; Phei WC; Garza J; Bernstein B; Stohl W
Arthritis Rheum; 2009 Nov; 60(11):3400-9. PubMed ID: 19877053
[TBL] [Abstract][Full Text] [Related]
11. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
13. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
Singh V; Mahoney JA; Petri M
J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
[TBL] [Abstract][Full Text] [Related]
15. Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus.
Balada E; Ordi-Ros J; Serrano-Acedo S; Martinez-Lostao L; Rosa-Leyva M; Vilardell-Tarrés M
Immunology; 2008 Jul; 124(3):339-47. PubMed ID: 18194272
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral blood leukocyte double strand RNA-dependent protein kinase gene expression in patients with systemic lupus erythematosus].
Li M; Liang Y; Yu WJ; Wu XH; Sha H; Huang XY
Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):855-8. PubMed ID: 23291021
[TBL] [Abstract][Full Text] [Related]
17. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus.
Urquizu-Padilla M; Balada E; Cortés F; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
J Rheumatol; 2009 May; 36(5):953-60. PubMed ID: 19332622
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M; Kim D; Oh M; Jeong H; Choi I
Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
[TBL] [Abstract][Full Text] [Related]
20. C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus.
Fyfe A; Holme ER; Zoma A; Whaley K
Clin Exp Immunol; 1987 Feb; 67(2):300-8. PubMed ID: 2955969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
